Your browser is out of date
With an updated browser, you will have a better Medtronic website experience. Update my browser now.
24-hour blood pressure lowering effect at three years
In the SPYRAL HTN-ON MED Pilot Study, at three years, blood pressure reductions with the Symplicity blood pressure procedure were present throughout the day and night, including the high-risk zone in the late night and early morning period, which is usually associated with increased risk for stroke and cardiovascular events.3
See data from the GLOBAL SYMPLICITY REGISTRY, the largest renal denervation data set.
Gain access to resources to introduce the Symplicity blood pressure procedure to your community successfully.
Discover a wide range of educational content about the Symplicity blood pressure procedure, including CME courses and presentations.
In typical uncontrolled hypertension patients.
RDN arm reduction from baseline.
ANCOVA adjusted; secondary efficacy analysis.
Kandzari DE, Böhm M, Mahfoud F, et al. Effect of renal denervation on blood pressure in the presence of antihypertensive drugs: 6-month efficacy and safety results from the SPYRAL HTN-ON MED proof-of-concept randomised trial. The Lancet. 2018;391:2346–2355.
Böhm M, Kario K, Kandzari DE, et al. Efficacy of catheter-based renal denervation in the absence of antihypertensive medications (SPYRAL HTN-OFF MED Pivotal): a multicentre, randomised, sham-controlled trial. The Lancet 2020; Published online March 29, 2020. DOI: 10.1016/ S0140-6736(20)30554-7.
Mahfoud F, Kandzari DE, Kario K, et al. Long-term efficacy and safety of renal denervation in the presence of antihypertensive drugs (SPYRAL HTN-ON MED): a randomised, sham-controlled trial. The Lancet. 2022; 399:1401-1410.